Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Pediatric Patients

NCT01919203 is registered in ClinicalTrials.gov with Sangjin Park as lead sponsor.

NCT NCT01919203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Pediatric Patients
Lead sponsor
Sangjin Park
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
July 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory complication